Navigation Links
Nestlé Recalls Raw Cookie Dough Products

Move comes after FDA reports 66 cases of E. coli infection in 28 states

FRIDAY, June 19 (HealthDay News) -- U.S. health officials are warning consumers not to eat any Nestlé Toll House refrigerated cookie dough products because of the risk of E. coli contamination.

In response to the Food and Drug Administration warning, Nestlé USA said Friday that it was voluntarily recalling its Toll House refrigerated cookie dough items.

"The E. coli outbreak could be from one or a number of contaminates, such as the milk component, the machinery, even the harvested flour," said one expert in infectious disease, Dr. Philip M. Tierno, director of clinical microbiology and immunology at New York University Langone Medical Center.

"Whether eaten or handled (causing cross-contamination), the dough is a danger, especially to the elderly, anyone with a suppressed immune system or pregnant women and should be discarded," he said.

Since March there have been 66 reports of illness in 28 states, the agency said. Twenty-five people have been hospitalized, seven with a severe complication called hemolytic uremic syndrome, which can result in kidney damage and even death. There have been no deaths, the FDA said.

The FDA is advising consumers to toss out any refrigerated Nestlé Toll House cookie dough products they have in their homes. The agency also says not to cook the dough because E. coli bacteria could get on your hands and cooking surfaces, leading to cross-contamination.

Retailers, restaurateurs, and other food-service operations should not sell or serve any Nestlé Toll House refrigerated cookie dough, the agency added.

The recall includes refrigerated cookie and brownie dough bar, cookie dough tub, cookie dough tubes, seasonal cookie and brownie dough, and Ultimates cookie bar dough. It does not include any other Toll House products, the company said in a news release.

Nestlé spokeswoman Roz O'Hearn said "this has been a very quickly moving situation," adding that the company took action less than 24 hours after hearing of the problem.

O'Hearn said the company will "cooperate fully" with the FDA's investigation, the Associated Press reported.

E. coli. can cause abdominal cramps, vomiting and diarrhea, often with bloody stools. Most healthy adults recover within a week. Young children and the elderly are at highest risk for developing hemolytic uremic syndrome, the FDA said.

More information

For more on E. coli, visit the U.S. Centers for Disease Control and Prevention.

SOURCES: Philip M. Tierno, M.D., director, Clinical Microbiology and Immunology, New York University Langone Medical Center, and clinical professor of microbiology and pathology, New York University School of Medicine, New York City; June 19, 2009, news release, U.S. Food and Drug Administration; Associated Press

Copyright©2009 ScoutNews,LLC.
All rights reserved

Related medicine news :

1. Pausing Hormone Therapy Doesnt Cut Mammogram Recalls
2. De Jong Bros. Recalls Spinach Because of Possible Health Risk
3. FDA Recalls Dietary Supplements Tied to 1 Death, Liver Damage
4. National Archives Recalls Flu Pandemic of 1918
5. Kroger Recalls Lite Mayo Due to Possible Health Risk
6. Kroger Recalls Shelled Pistachios Due to Possible Health Risk
7. Kroger Recalls Nut Topping Due to Possible Health Risk
8. Salmonella Infection Numbers Still Rising; Recalls Rise Also
9. Kroger Recalls Select Ice Cream Products Due to Possible Health Risk
10. Peanut Butter Product Recalls Mount
11. Ralcorp Frozen Bakery Products Recalls Food Lion Bake Shop Peanut Butter Cookies Nationwide Because of Possible Health Risk
Post Your Comments:
(Date:6/26/2016)... ... June 26, 2016 , ... PawPaws brand pet supplements ... was developed to enhance the health of felines. The formula is all-natural and is ... herbs in the PawPaws Cat Kidney Support Supplement Soft Chews are Astragalus ...
(Date:6/25/2016)... ... June 25, 2016 , ... Austin residents seeking Mohs ... College of Mohs Surgery and to Dr. Russell Peckham for medical and surgical dermatology. ... treatment for skin cancer. The selective fellowship in Mohs Micrographic Surgery completed by Dr. ...
(Date:6/25/2016)... , ... June 25, 2016 , ... As a lifelong ... Cum Laude and his M.D from the David Geffen School of Medicine at UCLA. ... to Los Angeles to complete his fellowship in hematology/oncology at the UCLA-Olive View-Cedars Sinai ...
(Date:6/24/2016)... , ... June 24, 2016 , ... A recent ... most people are unfamiliar with. The article goes on to state that individuals are ... many of these less common operations such as calf and cheek reduction. The Los ...
(Date:6/24/2016)... ... June 24, 2016 , ... ... Scientific Sessions in Dallas that it will receive two significant new grants to ... came as PHA marked its 25th anniversary by recognizing patients, medical professionals and ...
Breaking Medicine News(10 mins):
(Date:6/26/2016)... Australia,s successful biotechnology scientists, Dr Graham ... Noxopharm Limited [ABN 50 608 966 123] ("Noxopharm"). Noxopharm is seeking ... ASX. Noxopharm is a clinic-ready company with its first ... study later this year. NOX66 ... cancer patients - the ability of cancers to become resistant to ...
(Date:6/26/2016)... Jazz Pharmaceuticals plc (Nasdaq: JAZZ ) announced ... Act of 1976, as amended ("HSR"), with respect to ... CPXX ) expired effective June 24, 2016, ... previously announced on May 31, 2016, Jazz Pharmaceuticals and ... Jazz Pharmaceuticals has commenced a tender offer for all ...
(Date:6/26/2016)... June 27, 2016  VMS Rehab Systems, Inc. ( ... take whatever measures required to build a strong and ... is currently listed on the OTC Markets-pink current trading ... and CEO, "We are seeing an anomaly in market ... not only by the Company, but shareholders and market ...
Breaking Medicine Technology: